PD-L1 Expression in Receptor-Negative Breast Cancer Tissue
The obtained data indicated the expediency of using PD-L1 expression indicators for in-depth characterization of the tumor microenvironment of receptor-negative BCa, which will allow for the personalized correction of therapy regimens contributing to the improvement of the patients' quality of life.
Authors
- Taras Zadvornyi (ORCID: https://orcid.org/0000-0003-3033-3976)
- Oleksandr Mushii (ORCID: https://orcid.org/0000-0002-4666-9477)
- Mykhailo Krotevych (ORCID: https://orcid.org/0000-0002-5228-7491)
- Ye. A LUKIANOV
Institutions
- National Academy of Sciences of Ukraine (UA)
- R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology (UA)
- National Cancer Institute (UA)
Publication Details
- Journal
- Experimental Oncology
- Published
- 2025-02-20
- DOI
- https://doi.org/10.15407/exp-oncology.2024.04.324
- Citations
- 3
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 3.14
Funders
- Ministry of Education and Science of Ukraine